What is Leiomyosarcoma?

leiomyosarcoma is a type of cancer that develops in smooth muscle cells. It is an extremely rare cancer type; For example, in Units, the frequency of leiomyosarcoma is only 1.4 cases per 100,000 people. The prognosis for this type of cancer is generally poor, with a five -year survival rate ranging from 30 to 90 percent, depending on several factors. Involuntary muscle tissue is so -called because it is not possible to cause these muscles to move; The movement of these muscles occurs automatically in response to body stimuli. The most common places for the development of leiomyosarcoma are the gastrointestinal tract and uterus. All types can cause pain, swelling and formatinus lumps at a point of origin, although the lump is not always visible immediately. Uterine lump or gastrointestinal lump may not be immediately noticeable, while the lump on the skin will be recorded much earlier. When cancer develops in the gastrointestinal tract, it can cause abdominal bloating, gas, digestive problems or blood in the stool. In the case of cancer of the worksOhy is the main symptom of often abnormal vaginal bleeding.

For many people with cancer, bleeding is the main symptom. Bleeding can be slow and stable or occasional. In some cases, leiomyosarcoma bleeding may be haemorrhagic. If this happens, emergency medical treatments are required, generally involving one or more blood transfusions. Up to half of those with haemorrhagic bleeding may also require emergency surgery to find and stop bleeding.

leiomyosarcoma is only treatable in cases where cancer removal is viable treatment. If the entire tumor, in addition to local lymph nodes, can be successfully removed, if cancer does not spread to the nearest lymph nodes. This surgery is generally followed by chemotherapy or radiotherapy to kill all the remaining cancer cells. However, chemotherapy and radiation therapy do notThey are effective as separate treatment.

Although surgery can successfully treat cancer, it is not a guaranteed treatment. Cancer recurrence is more likely than possible, and due to the rarity of leiomyosarcoma, the standard for subsequent treatment has not been determined. In general, a patient treated for this disease will undergo annual scanning and blood tests to check the cancer recurrence.